{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:42:40Z","timestamp":1740148960459,"version":"3.37.3"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T00:00:00Z","timestamp":1607904000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T00:00:00Z","timestamp":1607904000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s12325-020-01575-9","type":"journal-article","created":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T10:04:45Z","timestamp":1607940285000},"page":"1068-1077","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Meta-analysis of Duration of Continuous Dual Antiplatelet Therapy and Late Stent Thrombosis After Second-Generation Drug Stent Implantation"],"prefix":"10.1007","volume":"38","author":[{"given":"Ming","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-chao","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ri-na","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2969-6833","authenticated-orcid":false,"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,12,14]]},"reference":[{"issue":"7521","key":"1575_CR1","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1136\/bmj.38603.656076.63","volume":"331","author":"TC Clayton","year":"2005","unstructured":"Clayton TC, Lubsen J, Pocock SJ, et al. Risk score for predicting death, myocardial infarction, and stroke in patients with stable angina, based on a large randomised trial cohort of patients. BMJ. 2005;331(7521):869.","journal-title":"BMJ"},{"issue":"9678","key":"1575_CR2","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","volume":"373","author":"C Baigent","year":"2009","unstructured":"Antithrombotic Trialists\u2019 (ATT) Collaboration, Baigent C, Blackwell L, et al. Aspirin in the primary and secondary prevention of vascular disease:collaborative meta-analysis of individual participant data from randomised trials. Lancet. 2009;373(9678):1849\u201360.","journal-title":"Lancet"},{"issue":"10","key":"1575_CR3","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1161\/01.CIR.0000140675.85342.1B","volume":"110","author":"KA Fox","year":"2004","unstructured":"Fox KA, Mehta SR, Peters R, et al. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the clopidogrel in unstable angina to prevent recurrent is chemic events (CURE) trial. Circulation. 2004;110(10):1202\u20138.","journal-title":"Circulation"},{"issue":"9038","key":"1575_CR4","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","volume":"348","author":"CAPRIE Steering Committee","year":"1996","unstructured":"CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348(9038):1329\u201339.","journal-title":"Lancet"},{"issue":"6","key":"1575_CR5","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1016\/j.ahj.2007.12.024","volume":"155","author":"GG Biondi-Zoccai","year":"2008","unstructured":"Biondi-Zoccai GG, Lotrionte M, Anselmino M, et al. Systematic review and meta-analysis of randomized clinical trials appraising the impact of cilostazol after percutaneous coronary intervention. Am Heart J. 2008;155(6):1081\u20139.","journal-title":"Am Heart J"},{"issue":"20","key":"1575_CR6","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","volume":"357","author":"SD Wiviott","year":"2007","unstructured":"Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007;357(20):2001\u201315.","journal-title":"N Engl J Med"},{"issue":"4","key":"1575_CR7","doi-asserted-by":"publisher","first-page":"447454","DOI":"10.1161\/CIR.0000000000000366","volume":"133","author":"D Mozaffarian","year":"2016","unstructured":"Mozaffarian D, Benjamin EJ, Go AS, et al. Executive summary: heart disease and stroke statistics\u20142016 update: a report from the American Heart Association. Circulation. 2016;133(4):447454. https:\/\/doi.org\/10.1161\/CIR.0000000000000366.","journal-title":"Circulation"},{"issue":"7","key":"1575_CR8","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1056\/NEJMe058140","volume":"353","author":"DJ Moliterno","year":"2005","unstructured":"Moliterno DJ. Healing Achilles\u2013sirolimus versus paclitaxel. N Engl J Med. 2005;353(7):724\u20137.","journal-title":"N Engl J Med"},{"issue":"16","key":"1575_CR9","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1161\/01.CIR.0000127110.49192.72","volume":"109","author":"GW Stone","year":"2004","unstructured":"Stone GW, Ellis SG, Cox DA, et al. One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Circulation. 2004;109(16):1942\u20137.","journal-title":"Circulation"},{"issue":"23","key":"1575_CR10","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1056\/NEJMoa012843","volume":"346","author":"MC Morice","year":"2002","unstructured":"Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346(23):1773\u201380.","journal-title":"N Engl J Med"},{"issue":"7","key":"1575_CR11","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1161\/01.CIR.0000086926.62288.A6","volume":"108","author":"A Colombo","year":"2003","unstructured":"Colombo A, Drzewiecki J, Banning A, et al. Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions. Circulation. 2003;108(7):788\u201394.","journal-title":"Circulation"},{"issue":"10","key":"1575_CR12","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1001\/jama.294.10.1215","volume":"294","author":"GW Stone","year":"2005","unstructured":"Stone GW, Ellis SG, Cannon L, et al. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA. 2005;294(10):1215\u201323.","journal-title":"JAMA"},{"issue":"20","key":"1575_CR13","first-page":"10","volume":"11","author":"H Niu","year":"2016","unstructured":"Niu H. Research of influence factors by anti-platelet aggregation drug inducing upper gastrointestinal hemorrhage. Chin Pract Med. 2016;11(20):10\u20131.","journal-title":"Chin Pract Med"},{"issue":"6","key":"1575_CR14","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.jacc.2003.10.039","volume":"43","author":"JA Bittl","year":"2004","unstructured":"Bittl JA, Chew DP, Topol EJ, et al. Meta-analysis of randomized trials of percutaneous transluminal coronary angioplasty versus atherectomy, cutting balloon atherotomy, or laser angioplasty. J Am Coll Cardiol. 2004;43(6):936\u201343.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"1575_CR15","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1056\/NEJM198703193161201","volume":"316","author":"U Sigwart","year":"1987","unstructured":"Sigwart U, Puel J, Mirkovitch V, et al. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med. 1987;316(12):701\u20136.","journal-title":"N Engl J Med"},{"key":"1575_CR16","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1161\/CIRCULATIONAHA.106.666800","volume":"115","author":"E Camenzind","year":"2007","unstructured":"Camenzind E, Steg PG, Wijns W. Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern. Circulation. 2007;115:1440\u201355.","journal-title":"Circulation"},{"issue":"23","key":"1575_CR17","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1093\/eurheartj\/ehl282","volume":"27","author":"AJ Nordmann","year":"2006","unstructured":"Nordmann AJ, Briel M, Bucher HC. Mortality in randomized controlled trials comparing drug-eluting vs. bare metal stents in coronary artery disease: a meta-analysis. Eur Heart J. 2006;27(23):2784\u2013814.","journal-title":"Eur Heart J"},{"key":"1575_CR18","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1056\/NEJMe1001069","volume":"362","author":"RA Lange","year":"2010","unstructured":"Lange RA, Hillis LD. Second-generation drug-eluting coronary stents. N Engl J Med. 2010;362:1728\u201330.","journal-title":"N Engl J Med"},{"key":"1575_CR19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/MCA.0b013e328333f550","volume":"21","author":"J Doostzadeh","year":"2010","unstructured":"Doostzadeh J, Clark LN, Bezenek S, et al. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent. Coron Artery Dis. 2010;21:46\u201356.","journal-title":"Coron Artery Dis"},{"issue":"5","key":"1575_CR20","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1161\/CIRCULATIONAHA.117.031843","volume":"137","author":"ZA Ali","year":"2018","unstructured":"Ali ZA, Gao R, Kimura T, et al. Three-year outcomes with the absorb bioresorbable scaffold: individual-patient-data meta-analysis from the ABSORB randomized trials. Circulation. 2018;137(5):464\u201379.","journal-title":"Circulation"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-020-01575-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-020-01575-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-020-01575-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T12:59:16Z","timestamp":1613739556000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-020-01575-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,14]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["1575"],"URL":"https:\/\/doi.org\/10.1007\/s12325-020-01575-9","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"type":"print","value":"0741-238X"},{"type":"electronic","value":"1865-8652"}],"subject":[],"published":{"date-parts":[[2020,12,14]]},"assertion":[{"value":"25 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}